Mpox in Nigeria

Monkeypox

Mpox in Nigeria refers to the occurrence and management of the Mpox virus within the Nigerian territory. Mpox, formerly known as Monkeypox, is a viral disease similar to smallpox, caused by the Mpox virus, a member of the Orthopoxvirus genus in the family Poxviridae. The disease is characterized by fever, rash, and swollen lymph nodes. Mpox is zoonotic, meaning it can be transmitted from animals to humans, with rodents and primates being the most common reservoirs. Human-to-human transmission is possible through close contact with infected bodily fluids, lesions, or contaminated materials.

Epidemiology in Nigeria

Nigeria has experienced Mpox cases and outbreaks since the first human case was reported in the 1970s. The country has seen an increase in the number of cases since a major outbreak in 2017, signaling a resurgence of the disease. The Nigerian Centre for Disease Control (NCDC) actively monitors and responds to Mpox cases, implementing measures to control the spread of the disease.

Transmission

In Nigeria, the transmission of Mpox primarily occurs through direct contact with the blood, bodily fluids, or cutaneous or mucosal lesions of infected animals. Secondary, or human-to-human, transmission can occur via respiratory droplets, contact with infected persons or contaminated materials. The rural regions, where interaction with wildlife is more common, typically report higher rates of animal-to-human transmission.

Symptoms and Treatment

The symptoms of Mpox include fever, headache, muscle aches, backache, swollen lymph nodes, chills, exhaustion, and a rash that can lead to lesions. The incubation period ranges from 5 to 21 days. Treatment is primarily supportive, focusing on relieving symptoms, as there is no specific treatment for Mpox. Vaccination against smallpox has been found to be about 85% effective in preventing Mpox, and antiviral drugs, though not widely available, can be used for severe cases.

Prevention and Control

Preventive measures in Nigeria include public health education on the risks of consuming wild game (bushmeat) and contact with wild animals. The NCDC and other health organizations emphasize the importance of hygiene practices, the use of personal protective equipment (PPE) when caring for infected individuals, and isolation of confirmed cases to prevent the spread of the virus.

Challenges

One of the main challenges in controlling Mpox in Nigeria is the limited public awareness and understanding of the disease, leading to delays in detection and reporting. Additionally, the similarity of Mpox symptoms to other endemic diseases, such as chickenpox, complicates diagnosis and response efforts. The rural setting of many outbreaks poses logistical challenges for surveillance, diagnosis, and treatment.

Conclusion

Mpox remains a public health concern in Nigeria, with sporadic outbreaks indicating the potential for wider spread. Continuous efforts in surveillance, public health education, and healthcare capacity building are essential to control and prevent Mpox in Nigeria. The collaboration between local health authorities, communities, and international health organizations is crucial in managing Mpox outbreaks and reducing their impact on public health.

Mpox in Nigeria Resources
Latest articles Most recent articles Ongoing trials	Wikipedia